Qiagen (NYSE:QGEN) Short Interest Update

Qiagen (NYSE:QGEN - Get Free Report) saw a significant drop in short interest during the month of December. As of December 31st, there was short interest totalling 3,060,000 shares, a drop of 18.0% from the December 15th total of 3,730,000 shares. Based on an average daily trading volume, of 864,900 shares, the days-to-cover ratio is presently 3.5 days. Approximately 1.4% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

QGEN has been the subject of a number of research reports. HSBC cut shares of Qiagen from a "buy" rating to a "hold" rating and set a $49.00 target price for the company. in a report on Thursday, October 17th. Jefferies Financial Group restated a "buy" rating and issued a $54.00 price objective (up from $42.00) on shares of Qiagen in a research note on Tuesday, December 10th. Hsbc Global Res raised Qiagen to a "hold" rating in a report on Thursday, October 17th. Finally, Morgan Stanley reaffirmed an "equal weight" rating and issued a $48.00 price objective (down previously from $50.00) on shares of Qiagen in a research note on Monday, January 6th. Four analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, Qiagen presently has an average rating of "Moderate Buy" and an average target price of $51.50.

Hedge Funds Weigh In On Qiagen

Several hedge funds have recently modified their holdings of QGEN. GAMMA Investing LLC increased its holdings in Qiagen by 806.5% in the 3rd quarter. GAMMA Investing LLC now owns 562 shares of the company's stock valued at $26,000 after acquiring an additional 500 shares during the last quarter. Toronto Dominion Bank purchased a new position in shares of Qiagen during the second quarter valued at about $27,000. Massmutual Trust Co. FSB ADV increased its holdings in shares of Qiagen by 39.8% in the third quarter. Massmutual Trust Co. FSB ADV now owns 853 shares of the company's stock worth $39,000 after purchasing an additional 243 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of Qiagen in the third quarter worth about $53,000. Finally, MassMutual Private Wealth & Trust FSB boosted its stake in Qiagen by 83.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,565 shares of the company's stock valued at $70,000 after buying an additional 712 shares during the last quarter. Hedge funds and other institutional investors own 70.00% of the company's stock.

Qiagen Price Performance

Shares of NYSE:QGEN traded up $0.13 during trading on Friday, hitting $46.03. 800,030 shares of the company's stock were exchanged, compared to its average volume of 864,314. The business's 50-day simple moving average is $44.17 and its 200 day simple moving average is $44.03. The company has a market cap of $10.50 billion, a price-to-earnings ratio of 118.04, a PEG ratio of 3.31 and a beta of 0.37. Qiagen has a 52-week low of $39.03 and a 52-week high of $47.44. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.17 and a quick ratio of 1.89.

Qiagen Company Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.